Compass Therapeutics Inc. (CMPX)

NASDAQ: CMPX · Real-Time Price · USD

1.91

0.09 (4.95%)

At close: May 02, 2025, 2:24 PM

Compass Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Mar 31, 2020	Mar 31, 2019
Net Income	-42.49M	-39.23M	-82.18M	-29.5M	-34.74M	-38.29M
Depreciation & Amortization	1.89M	1.9M	1.62M	2.4M	2.12M	1.92M
Stock-Based Compensation	6.12M	5.33M	4.03M	4.02M	915K	656K
Other Working Capital	-3.62M	-3.78M	6.44M	-4.03M	844K	1.18M
Other Non-Cash Items	5.97M	-871K	41K	-960K	116K	121K
Deferred Income Tax	n/a	n/a	50.58M	837K	109K	-261K
Change in Working Capital	-2.91M	-1.26M	6.25M	-3.6M	-257K	2.17M
Operating Cash Flow	-40.62M	-34.13M	-19.67M	-26.8M	-31.74M	-33.68M
Capital Expenditures	-30K	-212K	-1.57M	-106K	-466K	-2.02M
Cash Acquisitions	n/a	176K	116K	144K	n/a	n/a
Purchase of Investments	-155.42M	-200.12M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	182.41M	48.95M	n/a	n/a	n/a	n/a
Other Investing Acitivies	27K	-150.99K	-318K	144.00	n/a	n/a
Investing Cash Flow	26.96M	-151.2M	-1.77M	38K	-466K	-2.02M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-159	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-159K	-480K	-281K	-6.32M	37.63K	64.03M
Financial Cash Flow	2.94M	75.76M	118.61M	48.54M	37.63K	64.03M
Net Cash Flow	-10.72M	-109.57M	97.17M	21.77M	-32.21M	28.33M
Free Cash Flow	-40.65M	-34.34M	-21.23M	-26.91M	-32.21M	-35.7M